Previous close | 0.2800 |
Open | 0.3100 |
Bid | 0.3500 |
Ask | 0.4000 |
Strike | 40.00 |
Expiry date | 2023-03-17 |
Day's range | 0.3000 - 0.3900 |
Contract range | N/A |
Volume | |
Open interest | 304 |
Today, AlphaStruxure, a leader in Energy as a Service (EaaS) solutions, announced an agreement to design, construct, and operate integrated microgrid infrastructure at the New Terminal One (NTO) at John F. Kennedy International Airport. The microgrid will provide NTO with sustainable, resilient, locally generated, and cost-predictable energy. It will deliver immediate greenhouse gas emission reductions of 38 percent over grid-sourced energy and lead to cleaner air for the surrounding communities
Pathalys Pharma, Inc., a private, late-stage biopharma company co-founded by Catalys Pacific and DaVita Venture Group, and Launch Therapeutics (Launch Tx), a clinical development company, today announced a collaboration to advance phase 3 clinical trials for upacicalcet (designated PLS240 for clinical trials) for the treatment of secondary hyperparathyroidism (SHPT) in patients on hemodialysis. Launch Tx is backed by funds managed by global investment firm Carlyle (NASDAQ: CG) and its life scien
Vertical Capital Income Fund (NYSE: VCIF) (the "Fund") announced today that it has entered into a transaction agreement with an affiliate of global investment firm Carlyle (NASDAQ: CG), whereby upon obtaining approval by the Fund's shareholders Carlyle Global Credit Investment Management L.L.C. ("CGCIM") will become the investment adviser to the Fund (the "Transaction"). In addition, the Fund's investment mandate will change to focus on investing in equity and debt tranches of collateralized loa